ArticleJournal of clinical medicine2022

Plasma-Derived Hemopexin as a Candidate Therapeutic Agent for Acute Vaso-Occlusion in Sickle Cell Disease: Preclinical Evidence.

Thomas Gentinetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.